Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Allergan Inc Exploring Sale Of Obesity Business-Reuters


Tuesday, 30 Oct 2012 11:14am EDT 

Reuters reported that Allergan Inc was exploring a sale of its obesity business on falling sales of the only product in the unit. The Company expects sales of $160 million from its obesity intervention products unit for the full year. It sees total product net sales of between $5.69 billion and $5.77 billion. 

Company Quote

172.17
1.27 +0.74%
4:03pm EDT